Filing Details
- Accession Number:
- 0000904454-22-000601
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-01 16:14:30
- Reporting Period:
- 2022-11-29
- Accepted Time:
- 2022-12-01 16:14:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590560 | Uniqure N.v. | QURE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1692444 | Paula Soteropoulos | C/O Uniqure N.v. Paasheuvelweg 25A Amsterdam P7 11058BP | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-11-29 | 6,200 | $0.00 | 22,582 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-11-29 | 6,200 | $25.38 | 16,382 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2022-11-29 | 6,200 | $0.00 | 6,200 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,800 | 2023-06-06 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The Stock Option exercise price was EUR 10.10 per share or $10.46, as converted, based on the exchange rate at exercise of EUR 1 to $1.036.
- The Stock Option was granted on June 6, 2013 and vested 25% after one year, with the remainder vesting in weekly installments over a two year period ending on June 10, 2016.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.33 to $25.48. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
